Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: Patient- and nurse-reported results

This dataset presents the data of a study to explore the patient- and nurse-reported results of scalp cooling in terms of hair loss and need for a wig/head cover in patients with breast cancer treated with 3-weekly docetaxel 75 mg/m² - cyclophosphamide 600 mg/m².